Wei Song, M.D., Ph.D., is the Director of the Clinical Genomic Laboratory at the Englander Institute for Precision Medicine, an Assistant Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College and an Assistant Attending Pathologist at the NewYork-Presbyterian Hospital. In addition to overseeing the clinical genomics laboratory, reviewing sequencing runs, optimizing test platforms, and validating new tests, Dr. Song is dedicated to developing and validating new mutation profiling analysis in support of cancer treatments.
Dr. Song is focused on constructing automation of our Next Generation Sequencing NGS-based diagnostic pipelines, and comprehensive database of the precision medicine knowledge base (PMKB). With over 20 years of biomedical research experience, he completed his Ph.D. training at the University of Pennsylvania, has worked as HHMI fellow at the University of California San Francisco, and obtained a molecular genetics pathology fellowship training at Memorial Sloan Kettering Cancer Center. With the use of precision medicine tools, Dr. Song hopes to allow clinicians to expand their knowledge and make tailored treatment decisions not only for cancer, but also for cardiovascular, lung disease, neurological disease and diabetes.